Yale Catriona
SEC insider (Form 3/4/5 filer). CIK 0001779308. Chief Development Officer at Akero Therapeutics, Inc. (AKRO). 68 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Yale Catriona has filed insider reports for
- Akero Therapeutics, Inc. (AKRO): Officer, Chief Development Officer
Yale Catriona
CIK: 0001779308
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akero Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (68 total)
- Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect47.6K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect27.2K shares- - Nov 4, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect3.5K shares at avg. $28.35$100K - Nov 4, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect4.7K shares at avg. $21.10$100K - Sep 11, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect659 shares at avg. $43.02$28K - Jul 16, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect1.3K shares at avg. $53.47$72K - Jul 16, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect10K shares at avg. $19.87$199K - Jul 16, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect8.7K shares at avg. $52.87$458K - Jun 30, 2025AKRO
Akero Therapeutics, Inc.
AwardDirect890 shares at avg. $23.87$21K - Jun 18, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect1.6K shares at avg. $54.84$90K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 47,573 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 27,227 | - | - | Direct |
| Nov 4, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 3,527 | $28.35 | $99,990 | Direct |
| Nov 4, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 4,739 | $21.10 | $99,993 | Direct |
| Sep 11, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 659 | $43.02 | $28,350 | Direct |
| Jul 16, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 1,342 | $53.47 | $71,762 | Direct |
| Jul 16, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 10,000 | $19.87 | $198,700 | Direct |
| Jul 16, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 8,658 | $52.87 | $457,705 | Direct |
| Jun 30, 2025 | AKRO Akero Therapeutics, Inc. | Award | 890 | $23.87 | $21,243 | Direct |
| Jun 18, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 1,633 | $54.84 | $89,554 | Direct |
1-10 of 68 transactions